136 related articles for article (PubMed ID: 10542266)
1. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells.
Altiok S; Batt D; Altiok N; Papautsky A; Downward J; Roberts TM; Avraham H
J Biol Chem; 1999 Nov; 274(45):32274-8. PubMed ID: 10542266
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.
Hinton CV; Fitzgerald LD; Thompson ME
Exp Cell Res; 2007 May; 313(9):1735-44. PubMed ID: 17428466
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
Miralem T; Avraham HK
Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
[TBL] [Abstract][Full Text] [Related]
4. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.
Gonzalez ME; DuPrie ML; Krueger H; Merajver SD; Ventura AC; Toy KA; Kleer CG
Cancer Res; 2011 Mar; 71(6):2360-70. PubMed ID: 21406404
[TBL] [Abstract][Full Text] [Related]
6. Serine phosphorylation of paxillin by heregulin-beta1: role of p38 mitogen activated protein kinase.
Vadlamudi R; Adam L; Talukder A; Mendelsohn J; Kumar R
Oncogene; 1999 Dec; 18(51):7253-64. PubMed ID: 10602479
[TBL] [Abstract][Full Text] [Related]
7. Heregulin regulation of Akt/protein kinase B in breast cancer cells.
Liu W; Li J; Roth RA
Biochem Biophys Res Commun; 1999 Aug; 261(3):897-903. PubMed ID: 10441522
[TBL] [Abstract][Full Text] [Related]
8. Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.
Muraoka-Cook RS; Caskey LS; Sandahl MA; Hunter DM; Husted C; Strunk KE; Sartor CI; Rearick WA; McCall W; Sgagias MK; Cowan KH; Earp HS
Mol Cell Biol; 2006 Sep; 26(17):6412-24. PubMed ID: 16914727
[TBL] [Abstract][Full Text] [Related]
9. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
Adam L; Vadlamudi RK; McCrea P; Kumar R
J Biol Chem; 2001 Jul; 276(30):28443-50. PubMed ID: 11328805
[TBL] [Abstract][Full Text] [Related]
10. Akt-mediated survival of oligodendrocytes induced by neuregulins.
Flores AI; Mallon BS; Matsui T; Ogawa W; Rosenzweig A; Okamoto T; Macklin WB
J Neurosci; 2000 Oct; 20(20):7622-30. PubMed ID: 11027222
[TBL] [Abstract][Full Text] [Related]
11. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
[TBL] [Abstract][Full Text] [Related]
12. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
Jackson JG; St Clair P; Sliwkowski MX; Brattain MG
Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917
[TBL] [Abstract][Full Text] [Related]
13. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.
Carón RW; Yacoub A; Zhu X; Mitchell C; Han SI; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Mol Cancer Ther; 2005 Feb; 4(2):243-55. PubMed ID: 15713896
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and heregulin override DNA damage-induced growth arrest and promote phosphatidylinositol-3 kinase-dependent proliferation in breast cancer cells.
Chakravarti P; Henry MK; Quelle FW
Int J Oncol; 2005 Feb; 26(2):509-14. PubMed ID: 15645137
[TBL] [Abstract][Full Text] [Related]
15. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
Söderlund K; Pérez-Tenorio G; Stål O
Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
17. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
18. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
Lim SJ; Lopez-Berestein G; Hung MC; Lupu R; Tari AM
Oncogene; 2000 Dec; 19(54):6271-6. PubMed ID: 11175341
[TBL] [Abstract][Full Text] [Related]
19. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
20. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.
Ma Y; Hu C; Riegel AT; Fan S; Rosen EM
Mol Endocrinol; 2007 Aug; 21(8):1905-23. PubMed ID: 17505062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
